Immunosuppressive combination regimen
This page covers all Immunosuppressive combination regimen drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting IL-2 receptor (basiliximab), calcineurin (tacrolimus), IMPDH (MMF), glucocorticoid receptor (prednisolone).
Targets
Marketed (3)
- Basiliximab, Tacrolimus, MMF, Prednisolon · University Hospital Freiburg · Immunology / Transplantation
This is a multi-drug immunosuppressive regimen that blocks T-cell activation and proliferation to prevent organ rejection after transplantation. - Ponticelli Regimen · Beijing Friendship Hospital · Nephrology / Immunology
The Ponticelli Regimen is an immunosuppressive treatment protocol that combines corticosteroids and cyclophosphamide to suppress immune-mediated kidney damage. - Twice daily immunosuppression regimen · Washington University School of Medicine · Immunology
A twice-daily immunosuppressive regimen reduces immune system activity to prevent organ rejection or manage autoimmune conditions.